Correlation Between Viracta Therapeutics and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Revolution Medicines, you can compare the effects of market volatilities on Viracta Therapeutics and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Revolution Medicines.
Diversification Opportunities for Viracta Therapeutics and Revolution Medicines
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viracta and Revolution is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Revolution Medicines go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Revolution Medicines
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Revolution Medicines. In addition to that, Viracta Therapeutics is 4.82 times more volatile than Revolution Medicines. It trades about -0.04 of its total potential returns per unit of risk. Revolution Medicines is currently generating about -0.14 per unit of volatility. If you would invest 4,329 in Revolution Medicines on October 20, 2024 and sell it today you would lose (300.00) from holding Revolution Medicines or give up 6.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Revolution Medicines
Performance |
| Timeline |
| Viracta Therapeutics |
| Revolution Medicines |
Viracta Therapeutics and Revolution Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Revolution Medicines
The main advantage of trading using opposite Viracta Therapeutics and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |